0001104659-21-151719.txt : 20211220
0001104659-21-151719.hdr.sgml : 20211220
20211220163236
ACCESSION NUMBER: 0001104659-21-151719
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211216
FILED AS OF DATE: 20211220
DATE AS OF CHANGE: 20211220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SBLENDORIO GLENN
CENTRAL INDEX KEY: 0001277478
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 211505659
MAIL ADDRESS:
STREET 1: 3 TIMES SQAURE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 PENN PLAZA
STREET 2: SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: 5 PENN PLAZA
STREET 2: SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
tm2135829-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-16
0
0001410939
IVERIC bio, Inc.
ISEE
0001277478
SBLENDORIO GLENN
C/O IVERIC BIO, INC.
5 PENN PLAZA, SUITE 2372
NEW YORK
NY
10001
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
14.83
2021-12-16
4
A
0
252000
0
A
2031-12-16
Common Stock
252000
252000
D
Restricted Stock Units
2021-12-16
4
A
0
126000
0
A
Common Stock
126000
126000
D
Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest as follows: (1) no shares underlying the option shall vest unless, for a period of twenty consecutive trading days, the average closing sale price of the Registrant's common stock is equal to or exceeds 125% of the exercise price per share of such option (the "Performance Condition"), (2) subject to satisfaction of the Performance Condition, the option shall vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in equal monthly installments through the fourth anniversary of the grant date, and (3) such stock option shall be subject to "double-trigger" acceleration of vesting upon termination of employment following a change in control of the Registrant.
Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026).
/s/ Todd Anderman, as Attorney-in-Fact for Glenn P. Sblendorio
2021-12-20